473 related articles for article (PubMed ID: 15893176)
1. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
[TBL] [Abstract][Full Text] [Related]
2. The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.
Cai G; Zhang B; Shi G; Weng W; Ma C; Song Y; Zhang J
Lipids Health Dis; 2015 Nov; 14():149. PubMed ID: 26576960
[TBL] [Abstract][Full Text] [Related]
3. Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.
Anderson JM; Cerda A; Hirata MH; Rodrigues AC; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
J Clin Lipidol; 2014; 8(3):256-64. PubMed ID: 24793346
[TBL] [Abstract][Full Text] [Related]
4. Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.
Aung LH; Yin RX; Wu DF; Cao XL; Hu XJ; Miao L
Int J Med Sci; 2013; 10(2):124-32. PubMed ID: 23329883
[TBL] [Abstract][Full Text] [Related]
5. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
[TBL] [Abstract][Full Text] [Related]
6. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
Saavedra YG; Dufour R; Davignon J; Baass A
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
[TBL] [Abstract][Full Text] [Related]
7. What promise does PCSK9 hold?
Kastelein JJ; Fouchier SW; Defesche JC
J Am Coll Cardiol; 2005 May; 45(10):1620-1. PubMed ID: 15893177
[No Abstract] [Full Text] [Related]
8. The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women.
Evans D; Beil FU
BMC Med Genet; 2006 Jul; 7():66. PubMed ID: 16875509
[TBL] [Abstract][Full Text] [Related]
9. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.
Lutucuta S; Ballantyne CM; Elghannam H; Gotto AM; Marian AJ
Circ Res; 2001 May; 88(9):969-73. PubMed ID: 11349008
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
Hopkins PN; Defesche J; Fouchier SW; Bruckert E; Luc G; Cariou B; Sjouke B; Leren TP; Harada-Shiba M; Mabuchi H; Rabès JP; Carrié A; van Heyningen C; Carreau V; Farnier M; Teoh YP; Bourbon M; Kawashiri MA; Nohara A; Soran H; Marais AD; Tada H; Abifadel M; Boileau C; Chanu B; Katsuda S; Kishimoto I; Lambert G; Makino H; Miyamoto Y; Pichelin M; Yagi K; Yamagishi M; Zair Y; Mellis S; Yancopoulos GD; Stahl N; Mendoza J; Du Y; Hamon S; Krempf M; Swergold GD
Circ Cardiovasc Genet; 2015 Dec; 8(6):823-31. PubMed ID: 26374825
[TBL] [Abstract][Full Text] [Related]
11. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.
Marian AJ; Safavi F; Ferlic L; Dunn JK; Gotto AM; Ballantyne CM
J Am Coll Cardiol; 2000 Jan; 35(1):89-95. PubMed ID: 10636265
[TBL] [Abstract][Full Text] [Related]
12. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
[TBL] [Abstract][Full Text] [Related]
13. The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Aung LH; Yin RX; Miao L; Hu XJ; Yan TT; Cao XL; Wu DF; Li Q; Pan SL; Wu JZ
Lipids Health Dis; 2011 Jan; 10():5. PubMed ID: 21232153
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of polygenic cause in Korean patients with familial hypercholesterolemia - A study supported by Korean Society of Lipidology and Atherosclerosis.
Kwon M; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo J; Hur SH; Jeong JO; Jang Y; Lee SH; Lee JH
Atherosclerosis; 2015 Sep; 242(1):8-12. PubMed ID: 26160041
[TBL] [Abstract][Full Text] [Related]
15. The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype.
Drouin-Chartier JP; Tremblay AJ; Hogue JC; Ooi TC; Lamarche B; Couture P
Metabolism; 2015 Nov; 64(11):1541-7. PubMed ID: 26371983
[TBL] [Abstract][Full Text] [Related]
16. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan.
Hsu LA; Teng MS; Ko YL; Chang CJ; Wu S; Wang CL; Hu CF
Clin Chem Lab Med; 2009; 47(2):154-8. PubMed ID: 19191720
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
[TBL] [Abstract][Full Text] [Related]
18. A new PCSK9 gene promoter variant affects gene expression and causes autosomal dominant hypercholesterolemia.
Blesa S; Vernia S; Garcia-Garcia AB; Martinez-Hervas S; Ivorra C; Gonzalez-Albert V; Ascaso JF; Martín-Escudero JC; Real JT; Carmena R; Casado M; Chaves FJ
J Clin Endocrinol Metab; 2008 Sep; 93(9):3577-83. PubMed ID: 18559913
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
Page MM; Stefanutti C; Sniderman A; Watts GF
Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
[TBL] [Abstract][Full Text] [Related]
20. Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Li S; Zhang Y; Li XL; Guo YL; Zhu CG; Li JJ
Lipids Health Dis; 2014 Dec; 13():188. PubMed ID: 25496400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
